De novo a novel variant of CaSR gene in a neonate with congenital hypoparathyroidism
Annals of Pediatric Endocrinology & Metabolism
;
: 107-111, 2018.
Article
in English
| WPRIM
| ID: wpr-714969
ABSTRACT
Autosomal-dominant hypocalcemia with hypercalciuria (ADHH) is a genetic disease characterized by hypoparathyroidism with hypercalciuria. Most patients with ADHH have calcium-sensing receptor (CaSR) gene mutations. The CaSR gene controls parathyroid secretions, and mutations in this gene can be detected via changes in serum calcium level. The activating mutation of the CaSR gene results in familial or sporadic ADHH. Most activating mutations of the CaSR gene are reportedly de novo missense mutations. This is the first case report of a novel activating variant of the CaSR gene in a neonate with congenital hypoparathyroidism with hypomagnesemia and hypercalciuria. We also report the 3-month follow-up management of the patient.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Calcium
/
Follow-Up Studies
/
Mutation, Missense
/
Receptors, Calcium-Sensing
/
Hypercalciuria
/
Hypocalcemia
/
Hypoparathyroidism
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
/
Infant, Newborn
Language:
English
Journal:
Annals of Pediatric Endocrinology & Metabolism
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS